Nature Chemical Biology Impact Factor

The 15.8 JIF places Nature Chemical Biology in the top 4% of Biochemistry & Molecular Biology. The five-year JIF (16.2) running above the two-year figure tells you papers here continue to accumulate citations over time, consistent with a journal that publishes work with lasting reference value at the chemistry-biology interface.

Nature Chemical Biology publishes a relatively low volume of citable items compared with broad chemistry flagships, which means the journal is selective and each paper gets strong editorial attention and Nature Portfolio promotion. The total citation count is solid for a specialty journal, reflecting the chemical biology community's engagement with its content.

At 15.8, Nature Chemical Biology sits below JACS (16.6) and Angewandte Chemie (17.6) on raw JIF, but it serves a fundamentally different audience. Those chemistry flagships publish across all of chemistry. Nature Chemical Biology specifically serves the community working at the interface, and for that audience, it's the most prestigious dedicated venue.

Evidence basis: this page was updated against Nature Chemical Biology's current journal metrics page, the 2026 Journal Citation Reports release context, Nature Chemical Biology author materials, and our Manusights review work on chemical-biology manuscripts. We separate the official metric row from submission-fit interpretation because the same 15.8 JIF can mean different things for a chemistry-first paper, a biology-first paper, and a genuinely integrated chemical-biology paper.

In our metric review work, the recurring failure pattern is treating Nature Chemical Biology as a midpoint between JACS and a biology journal. Editors screen for whether chemistry changes the biological answer, not simply whether the metric sits near broad chemistry flagships. That is why this page pairs the JIF with SJR, SNIP, trend context, and the fit tests below.

Nature Chemical Biology has grown from roughly the low-teens range to a current 15.8. The current 2025 JIF is up from 13.7 in the prior data year and reflects the journal's structural position at the chemistry-biology interface.

• whether the chemistry in your paper genuinely illuminates the biology

• how the Nature Portfolio review process will handle interdisciplinary work

• how long the review and revision cycle will take

• whether JACS or Angewandte Chemie would give the chemistry broader visibility

• how your specific paper will perform relative to the journal average

For manuscripts targeting Nature Chemical Biology, three editorial flags drive early rejection most frequently. The journal does not publish a current desk-rejection percentage, but its editorial policy says every submission is read by editorial staff and only papers most likely to meet the criteria are sent for formal review.

Chemistry with biology as validation rather than discovery.

The journal's editorial identity requires that the chemical advance unlock a biological question, not that biology confirm the chemistry works. Papers that develop a new probe, sensor, or small molecule and use cell-based assays to show it functions in biological systems face rejection when the biology is confirmation rather than discovery. If removing the biological experiments from the paper would leave a chemistry paper that still makes its key claim, the manuscript belongs in JACS, Angewandte Chemie, or Nature Chemistry.

The test Nature Chemical Biology editors apply: does the chemical approach reveal something about how biology works that could not have been discovered without it? If the answer is "the chemical tool is useful, and the biology experiments show it works," that is chemistry-first framing. If the answer is "we couldn't have discovered this biological principle without this chemical approach," that is the Nature Chemical Biology framing.

Phenomenological biology without molecular mechanism. Papers showing that a chemical compound induces a biological phenotype without explaining the molecular mechanism of how and why fail the journal's standards even when the biology is interesting. "Compound X inhibits cancer cell growth via pathway Y" with pathway-level data but no molecular mechanism for how the compound engages that pathway is phenomenological. The journal expects chemical probes to deliver mechanistic resolution at the molecular level, not only phenotypic readouts.

The chemical approach should enable access to mechanistic questions that genetic or other biological approaches cannot answer, and the paper should show that mechanistic answer, not just a phenotype.

Insufficient accessibility for the cross-disciplinary readership. Nature Chemical Biology serves readers with either chemistry or biology backgrounds who are reading outside their primary expertise. Papers that assume specialist chemistry knowledge when explaining the biological context, or assume molecular biology fluency when explaining the chemical synthesis, create accessibility failures that trigger editorial concern. The introduction must explain why the biological problem matters to chemists and why the chemical approach is non-obvious to biologists.

A paper that chemists can follow but biologists cannot, or vice versa, is not fully positioned for this journal's audience. A Nature Chemical Biology integration and cross-disciplinary framing check can assess whether the chemical-biological integration and cross-disciplinary framing meet Nature Chemical Biology's bar.

Nature Chemical Biology has a strict editorial requirement that separates it from both chemistry and biology journals: the paper must genuinely integrate chemistry and biology. This isn't a soft preference. It's a hard filter.

Papers that fit:

• chemical probes that reveal new biology (the chemistry enables the biological discovery)

• drug mechanism studies where the chemical understanding drives the biological insight

• metabolomics or chemical genetics that changes understanding of a biological pathway

• engineered proteins or nucleic acids where the chemical design is integral to function

• natural product studies where biosynthesis and biological activity are both explored

Papers that don't fit:

• pure chemistry (even excellent chemistry) without biological insight

• pure biology (even excellent biology) that happens to use chemical tools

• drug discovery papers where the chemistry is routine and the biology is the news

• materials chemistry with a biological application bolted on

• computational chemistry without experimental validation of biological relevance

Editors want work where removing either the chemistry or the biology would fundamentally break the story. If the chemical approach reveals something about biology that no other approach could, that's a Nature Chemical Biology paper. If the biology could stand alone without the chemistry, or vice versa, it belongs elsewhere.

The journal has strong coverage in:

• chemical probe development and application

• enzyme mechanism and catalysis

• metabolic pathway discovery

• chemical genetics and pharmacology

• protein and nucleic acid engineering

• natural product biosynthesis and function

Submit if:

• the paper sits at the chemistry-biology interface with genuine integration

• the chemical approach reveals biological insight that couldn't come any other way

• the work has broad enough relevance for a Nature Portfolio venue

• both the chemistry and biology are high-quality, not just one or the other

Think twice if:

• the paper is primarily chemistry with biology bolted on (target JACS or Angew. Chemie)

• the work is primarily biology that uses chemical tools (target a biology journal)

• ACS Chemical Biology would provide adequate visibility at lower risk

• the integration of chemistry and biology is forced rather than natural

• Cell Chemical Biology's editorial approach would better serve the paper

Nature Chemical Biology's 15.8 is best read as a specialist-flagship signal, not as a simple chemistry prestige score. The journal sits below JACS and Angewandte Chemie International Edition on raw JIF, but that comparison misses the actual editorial logic. Nature Chemical Biology exists to reward papers where chemistry changes the biological answer. If the paper would still be essentially the same story after you removed either the chemistry or the biology, the impact factor is not telling you the full submission truth.

That is why the trend matters more than the snapshot. A stable, high-teens five-year JIF tells you papers here keep being cited after the initial publication moment because they often become reference points for probe design, target validation, pathway interrogation, and chemical genetics strategy. The journal is not just visible. It is useful to the exact community that works across both disciplines.

Use the trend as a guardrail against forced interdisciplinarity. Nature Chemical Biology is strongest when the paper would look incomplete without both halves of the story, and that is the standard the current metric is really reflecting.